TRIP13 Antikörper (N-Term)
Kurzübersicht für TRIP13 Antikörper (N-Term) (ABIN358019)
Target
Alle TRIP13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody detects TRIP13 (N-term).
-
Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
-
Immunogen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human TRIP13.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western Blot: 1/50-1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
-
- TRIP13 (Thyroid Hormone Receptor Interactor 13 (TRIP13))
-
Andere Bezeichnung
- TRIP13
-
Hintergrund
- TRIP13 specifically interacts with the ligand binding domain of the thyroid receptor (TR). This interaction does not require the presence of thyroid hormone for its interaction.Synonyms: 16E1-BP, HPV16 E1 protein-binding protein, Human papillomavirus type 16 E1 protein-binding protein, TRIP-13, Thyroid hormone receptor interactor 13, Thyroid receptor-interacting protein 13
-
Molekulargewicht
- 48551 Da (Theoretical pI = 5.73)
-
Gen-ID
- 9319, 9606
-
UniProt
- Q15645
Target
-